USPTO serial 90645222
CUREBEST
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- MANCA, ALBERTO I
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CUREBEST?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Virginia Wolk Marino
Virginia Wolk Marino CROWELL & MORINGP.O. BOX 10395CHICAGO, IL 60610United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Medical laboratory services, namely, clinical laboratory testing services and reporting of results for others for medical and scientific research purposes; Medical testing and research services in the field of genes, proteins and cells, and reporting of results for medical and scientific research purposes; Providing medical and scientific research information regarding diagnostic testing results and disease conditions; Providing laboratory research services in the field of gene expression; Gene expression analysis service for others in the nature of genetic testing for medical and scientific research purposes; Scientific research for medical purposes in the area of cancerous diseases; Medical research in the field of cancer diagnosis and cancer treatment; Providing medical and scientific research information in the field of forecasting and predicting a recurrence of cancer; Analytic and diagnostic testing services for medical and scientific research purposes, namely, the analysis of biological samples for forecasting and predicting a recurrence of cancer | ACTIVE | — |
| 044 | Providing medical and scientific testing and research information in the field of genetics; Providing information regarding medical diagnostic testing results and disease conditions for medical diagnosis purposes; Providing medical diagnostic testing, monitoring, analysis, evaluation and reporting services, and information related thereto in the field of genetics; Providing medical diagnostic testing, monitoring, analysis, evaluation and reporting services, and information related thereto in the field of cancer diagnosis; Gene, protein and cell analysis for medical diagnostic testing purposes; Medical analyses, in particular gene, protein and cell analyses for diagnosing cancer and forecasting the expected progress of a cancerous illness; Clinical laboratory testing service for medical diagnostic purposes specifically for forecasting and predicting a recurrence of cancer; Medical services, in particular, laboratory testing services comprising the analysis of biological samples for medical diagnostic purposes specifically for forecasting and predicting a recurrence of cancer | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 2, 2024 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 2, 2024 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 2, 2024 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 2, 2024 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 9, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 7, 2024 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Feb 7, 2024 | EXT4 | SOU EXTENSION 4 FILED | — |
| Feb 7, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 12, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 10, 2023 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Aug 10, 2023 | EXT3 | SOU EXTENSION 3 FILED | — |
| Aug 10, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 1, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 27, 2023 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Feb 27, 2023 | EXT2 | SOU EXTENSION 2 FILED | — |
| Feb 27, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 5, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 3, 2022 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 3, 2022 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 3, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 3, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 3, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Aug 3, 2022 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Aug 3, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 3, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 19, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Feb 22, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 22, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 2, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 18, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 23, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 22, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 22, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 13, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 13, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 13, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 5, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 22, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 12, 2021 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Jul 12, 2021 | ALIE | ASSIGNED TO LIE | — |
| Jun 28, 2021 | ALIE | ASSIGNED TO LIE | — |
| Apr 20, 2021 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Apr 17, 2021 | NWAP | NEW APPLICATION ENTERED | — |